Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

11.25
-0.3700-3.18%
Post-market: 11.250.00000.00%19:36 EDT
Volume:144.45K
Turnover:1.65M
Market Cap:562.51M
PE:-9.49
High:11.69
Open:11.68
Low:11.24
Close:11.62
Loading ...
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 16, 2021

Major Issues Report

8-K - Current report
Dec 06, 2021

Major Issues Report

8-K/A [Amend] - Current report
Nov 16, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2021

Major Issues Report

8-K - Current report
Oct 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 05, 2021

Major Issues Report

8-K/A [Amend] - Current report
Sep 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2021

Major Issues Report

8-K - Current report
Sep 07, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2021

Major Issues Report

8-K - Current report